InsiderTrades

Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.

Accepted 2026-05-22 16:18:46 ET · period of report 2026-05-20 · accession 0001178670-26-000041 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-22 16:18 2026-05-20 ALNY SCHULMAN AMY W Dir A - Grant $0.00 +838 24.0K +4% $0
D 2026-05-22 16:18 2026-05-20 ALNY SCHULMAN AMY W Dir A - Grant $0.00 +1,802 1,802 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-20 A A 838 $0.00 24,049 D — — (F1) These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
2 Derivative Stock Option (Right to Buy) 2026-05-20 A A 1,802 $0.00 1,802 D $298.48 · 2027-05-20 to 2036-05-20 1,802 Common Stock (F2) The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.